TETRALOGIC PHARMACEUTICALS CORP Contracts & Agreements
56 Contracts & Agreements
- Business Finance (26 contracts)
- Business Operations (6)
- Human Resources (15)
- Intellectual Property (2)
- Mergers & Acquisitions (1)
- Real Estate (1)
- Uncategorized (5)
- FORM OF EXCHANGE AND CONSENT AGREEMENT (Filed With SEC on November 14, 2016)
- ASSET PURCHASE AGREEMENT BY AND AMONG TETRALOGIC PHARMACEUTICALS CORPORATION, TETRALOGIC RESEARCH AND DEVELOPMENT CORPORATION AND MEDIVIR AB DATED AS OF NOVEMBER 2, 2016 (Filed With SEC on November 3, 2016)
- TETRALOGIC PHARMACEUTICALS CORPORATION Debt Exchange November 2, 2016 (Filed With SEC on November 3, 2016)
- VOTING AGREEMENT (Filed With SEC on November 3, 2016)
- CONSULTING AGREEMENT (Filed With SEC on August 11, 2016)
- PURCHASE AGREEMENT (Filed With SEC on August 25, 2015)
- EXCHANGE AGREEMENT (Filed With SEC on May 14, 2015)
- EXCHANGE AGREEMENT (Filed With SEC on May 14, 2015)
- FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 14, 2015)
- TETRALOGIC PHARMACEUTICALS CORPORATION (Filed With SEC on May 1, 2015)
- TETRALOGIC PHARMACEUTICALS CORPORATION AT-THE-MARKET EQUITY OFFERING SALES AGREEMENT (Filed With SEC on March 13, 2015)
- INDEMNIFICATION AGREEMENT (Filed With SEC on November 10, 2014)
- MERGER AGREEMENT by and among SHAPE PHARMACEUTICALS, INC. TETRALOGIC PHARMACEUTICALS CORPORATION, TLOG ACQUISITION SUB, INC., and AUGUSTINE LAWLOR as HOLDER REPRESENTATIVE, April... (Filed With SEC on August 5, 2014)
- LICENSE AGREEMENT (Filed With SEC on August 5, 2014)
- Licence Agreement The Walter & Eliza Hall Institute of Medical Research TetraLogic Pharmaceuticals Corporation (Filed With SEC on August 5, 2014)
- TETRALOGIC PHARMACEUTICALS CORPORATION $47,000,000 Convertible Senior Notes due 2019 PURCHASE AGREEMENT June 17, 2014 (Filed With SEC on August 5, 2014)
- TETRALOGIC PHARMACEUTICALS CORPORATION AS ISSUER 8.00% CONVERTIBLE SENIOR NOTES DUE 2019 INDENTURE Dated as of June 23, 2014 U.S. BANK NATIONAL ASSOCIATION as Trustee (Filed With SEC on June 23, 2014)
- TETRALOGIC PHARMACEUTICALS CORPORATION 8.00% Convertible Senior Note due 2019 No. 1 $47,000,000 (Filed With SEC on June 23, 2014)
- TETRALOGIC PHARMACEUTICALS CORPORATION EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on June 5, 2014)
- TETRALOGIC PHARMACEUTICAL CORPORATION AMENDED AND RESTATED 2013 EQUITY INCENTIVE PLAN (Filed With SEC on December 10, 2013)
- THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on November 18, 2013)
- TetraLogic Pharmaceuticals Corporation Common Stock ($0.0001 Par Value) EQUITY UNDERWRITING AGREEMENT (Filed With SEC on November 6, 2013)
- AMENDMENT NO. 1 TO WARRANT TO PURCHASE EQUITY SECURITIES OF TETRALOGIC PHARMACEUTICALS CORPORATION (Filed With SEC on November 6, 2013)
- TETRALOGIC PHARMACEUTICALS CORPORATION 2013 EQUITY INCENTIVE PLAN (Filed With SEC on November 6, 2013)
- TETRALOGIC PHARMACEUTICALS CORPORATION PERFORMANCE BONUS PLAN (Filed With SEC on November 6, 2013)
- INDEMNIFICATION AGREEMENT (Filed With SEC on November 6, 2013)
- THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on November 6, 2013)
- TETRALOGIC PHARMACEUTICALS CORPORATION WARRANT TO PURCHASE EQUITY SECURITIES (Filed With SEC on October 31, 2013)
- TETRALOGIC PHARMACEUTICALS CORPORATION UNSECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 31, 2013)
- WARRANT TO PURCHASE STOCK (Filed With SEC on October 18, 2013)
- WARRANT TO PURCHASE STOCK (Filed With SEC on October 18, 2013)
- Void after 5:00 p.m. New York Time on the Expiration Date (as defined below) Warrant to Purchase Shares of Convertible Preferred Stock (Filed With SEC on October 18, 2013)
- Void after 5:00 p.m. New York Time on the Expiration Date (as defined below) Warrant to Purchase Shares of Convertible Preferred Stock (Filed With SEC on October 18, 2013)
- Void after 5:00 p.m. New York Time on the Expiration Date (as defined below) Warrant to Purchase Shares of Common Stock (Filed With SEC on October 18, 2013)
- Void after 5:00 p.m. New York Time on the Expiration Date (as defined below) Warrant to Purchase Shares of Common Stock (Filed With SEC on October 18, 2013)
- TETRALOGIC PHARMACEUTICALS CORPORATION WARRANT TO PURCHASE EQUITY SECURITIES (Filed With SEC on October 18, 2013)
- TETRALOGIC PHARMACEUTICALS CORPORATION WARRANT TO PURCHASE EQUITY SECURITIES (Filed With SEC on October 18, 2013)
- TETRALOGIC PHARMACEUTICALS CORPORATION UNSECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 18, 2013)
- TETRALOGIC PHARMACEUTICALS CORPORATION UNSECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 18, 2013)
- TETRALOGIC PHARMACEUTICALS CORPORATION NOTE PURCHASE AGREEMENT (Filed With SEC on October 18, 2013)
- SECOND AMENDED AND RESTATED VOTING AGREEMENT (Filed With SEC on October 18, 2013)
- SECOND AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT (Filed With SEC on October 18, 2013)
- EXCLUSIVE LICENSE AGREEMENT between LICENSEE and PRINCETON UNIVERSITY (Filed With SEC on October 18, 2013)
- TETRALOGIC PHARMACEUTICALS CORPORATION 2004 EQUITY INCENTIVE PLAN (Filed With SEC on October 18, 2013)
- MANAGEMENT TRANSITION AGREEMENT (Filed With SEC on October 18, 2013)
- CONSULTING AGREEMENT (Filed With SEC on October 18, 2013)
- TETRALOGIC PHARMACEUTICALS CORPORATION EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 18, 2013)
- TETRALOGIC PHARMACEUTICALS CORPORATION EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 18, 2013)
- TETRALOGIC PHARMACEUTICALS CORPORATION EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 18, 2013)
- TETRALOGIC PHARMACEUTICALS CORPORATION EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 18, 2013)
- TETRALOGIC PHARMACEUTICALS CORPORATION EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 18, 2013)
- TETRALOGIC PHARMACEUTICALS CORPORATION SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 18, 2013)
- 343 Phoenixville Pike Malvern, PA 19355 P ###-###-#### F ###-###-#### www.tetralogicpharma.com 1 (Filed With SEC on October 18, 2013)
- Advisory Services Agreement (Filed With SEC on October 18, 2013)
- OFFICE/LABORATORY LEASE (Filed With SEC on October 18, 2013)
- SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on October 18, 2013)
